Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk
Files
Publication date
2016-08-01
Authors
Van Den Elzen, M. T.
van Os-Medendorp, H.
Röckmann, Heike
van Hoffen, Els
Lebens, Ans F M
van Doorn, Helma
Klemans, R. J. B.
Bruijnzeel-Koomen, Carla A.
Hack, Erik
Kaufman, Leonard
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Background Recombinant human C1 inhibitor (rhC1INH) for on-demand treatment of hereditary angioedema is purified from milk of transgenic rabbits. It contains low amounts (
Keywords
allergenicity, cow's milk allergy, Hereditary angioedema, intracutaneous test, intradermal testing, rabbit allergy, recombinant human C1 esterase inhibitor, skin prick test, subcutaneous administration, subcutaneous challenge, Taverne, Immunology and Allergy, Immunology, Journal Article
Citation
van den Elzen, M T, van Os-Medendorp, H, Röckmann-Helmbach, H, van Hoffen, E, Lebens, A F M, van Doorn, H, Klemans, R J B, Bruijnzeel-Koomen, C A F M, Hack, C E, Kaufman, L, Relan, A & Knulst, A C 2016, 'Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk', Journal of Allergy and Clinical Immunology, vol. 138, no. 2, pp. 476-481.e1. https://doi.org/10.1016/j.jaci.2016.04.019